Background: The aim of this prospective multicentre study was to define accuracy of lung
Introduction
Community-acquired pneumonia (CAP) is the most common disease recorded worldwide, and 2-3 million cases are diagnosed annually in the United States. In an appropriate clinical setting, diagnosis of pneumonia is established in case of a new infiltrate on chest X-ray. However, due to the methodological limitations of X-ray, computed tomography (CT) is regarded as "gold standard", allowing a diagnosis of pneumonia earlier and with a higher sensitivity and specificity [1] . Limitations of CT include radiation dose, higher costs and reduced availability [2] .
Lung ultrasound (LUS) represents a new technique for diagnosing pleural and pulmonary diseases [3] [4] [5] [6] [7] [8] [9] . The primary objective of this study was to determine the accuracy of LUS in diagnosing CAP compared to chest X-ray in two planes and, in case of equivocal or negative Xray but positive LUS results, to low-dose CT. Secondarily, the appropriateness of LUS for CAP follow-up was explored.
Methods
This was an international, multicentre, prospective, observational study in patients with suspected CAP in 14 European centres (two University hospitals, seven hospitals of internal medicine, one of pulmonary medicine, two practices and two emergency departments).
The institutional review board approved the study protocol (number 2055-06/07) and patients provided written, informed consent before enrolment. This study is registered at ClinicalTrials.gov, NCT00808457, and is reported according to the STARD statement [10] .
Patients
Patients with clinically suspected CAP were enrolled in the study. Suspicion of CAP was raised clinically (fever > 38.0°C, cough, purulent expectoration, dyspnea) and / or on the basis of typical auscultation findings (rales or bronchial breath sounds).
Patient history regarding comorbidity/risk factors was documented on day 0. Clinical symptoms of pneumonia were assessed on day 0, between day 5-8 and day [13] [14] [15] [16] . Clinical examination at the same time points was focused on auscultation. Laboratory testing included C-reactive protein and leucocytes on day 0 and between day 13-16.
Inclusion criteria were patients with suspected CAP who are able to undergo chest X-ray in two planes as well as age over 18 years. Exclusion criteria involved prior systemic antibiotic therapy, hospital-acquired pneumonia and/or severe immunosuppression, more than 24 hours between LUS and X-ray/low-dose CT, X-ray findings known to the sonographer, pregnancy and/or lactation.
Lung ultrasound
Lung ultrasound was performed first. Patients in whom a chest X-ray had already been performed at the time of the ultrasound investigation could be enrolled, if LUS was performed within 24 hours after X-ray and if the X-ray findings were neither available nor known to the sonographer.
Sonography was conducted using a 5 or 3.5 MHz convex scanner, respectively, while examination by a 7.5 MHz linear scanner was occasionally performed. Patients were examined posteriorly in a seated and anteriorly in a supine position. A systematic examination of all intercostal spaces was performed by experienced physicians who have done at least 100 chest ultrasounds.
Sonography was assessed for the number, location, shape, size, and breath-dependant movement of pneumonia. Furthermore, the incidence of necrotic areas, positive air bronchogram, fluid bronchogram, as well as local and/or basal pleural effusion was reviewed on day 0, between day 5-8 and between day 13-16.
Chest radiography
All patients underwent postero-anterior and lateral chest radiography on day 0 and if possible between days 13 to 16. X-rays were analysed by independent experts in chest radiology unaware of LUS results.
Computed tomography
In the case of inconclusive X-ray or in the case of positive sonography and negative X-ray, a low-dose CT was performed without contrast medium, using 120 kV, 20 to 40 mA and a 
Statistical analysis
The primary objective was to estimate the diagnostic accuracy of LUS as index test (positive/negative/equivocal) compared to X-ray on two planes followed by CT in case of inconclusive or negative X-ray but positive ultrasound as the reference test (negative/positive).
A total sample size of 300 patients was considered as necessary and feasible to estimate a sensitivity of 80% with a precision (half of the 95% confidence interval (CI)) of 5.1% if the prevalence of CAP was 80%. According to the study protocol sensitivity, specificity and likelihood ratios (LR) were estimated excluding equivocal LUS results (primary analysis). All three test categories were included in an analysis of robustness. Exact 95% CI were calculated for sensitivity and specificity assuming a binomial distribution. Asymptotic CIs were computed for LR [18] . Baseline characteristics, clinical, sonographic and laboratory data were displayed by adequate descriptive statistics. Agreement of LUS and X-ray diagnoses was assessed by the kappa coefficient. Bland-Altman plots were constructed to compare the extension of pneumonic lesions measured by LUS and X-ray. Data were analysed using SAS (version 9.2; SAS Institute, Cary, NC). 
Results

Between
Baseline characteristics of the patients
The patients had a median age of 63.8 (range 19-95) years and male gender was slightly overbalanced (63.0%). Ninety-five percent were inpatients. The baseline characteristics of the patients are shown in Table 1 .
Diagnostic accuracy of lung ultrasound
At baseline, CAP was diagnosed by LUS in 214 (59.1%) patients, 142 (39.2%) patients had negative, and 6 (1.7%) had equivocal findings ( Figure 1 , Table 2 In comparison to LUS, X-ray alone revealed 199 (55.0%) positive, 138 (38.1) negative and 25 (6.9%) equivocal findings ( Table 2 ). In patients with unequivocal X-ray results, pneumonia was correctly diagnosed by X-ray in 199 (92.6%) of 215 CAP patients and correctly ruled out in 122 (100%) patients. Since X-ray was a part of the final diagnosis, these figures should not be interpreted as sensitivity and specificity. However, comparing LUS to X-ray, 26 cases of LUSdetected CAP were missed or equivocal by X-ray, whereas X-ray detected 14 cases of CAP which were missed by LUS.
Sonomorphology of CAP at baseline and during follow-up
Patients with sonographically detected and confirmed pneumonia (n=211) showed consolidations, most frequently on the right side (45.5%), and in 15.2% on both sides of the lung (Table 3) . 22.6% of the patients had more than one lesion at baseline. The shape of the lesions was mostly polygonal (51.2%) or oval (46.3%) with blurred margins (76.5%). Median surface extension of the lesions at baseline in cm (interquartile range) was 3.2 (1.7-5.0) and depth 3.7 (2.2-5.7). Nearly all consolidations revealed breath-dependant motion (97.6%) and 86.7% had an air bronchogram (Figure 2) , whereas only 8.1% showed a fluid bronchogram. A basal pleural effusion was evident in 54.4% at baseline with a median volume of 50 ml. During follow-up, the median number of symptoms per patient reduced from three to one, median C-reactive protein levels declined from 137 mg/dl to 6.3 mg/dl, and leucocyte numbers decreased from 11.7 Gpt/l to 7.4 Gpt/l on day 13-16.
Disease remission could be also demonstrated sonographically. The proportion of patients with air bronchogram decreased from 86.7% to 71.2% (47/66), the area of pneumonic lesions from 15.3 to 6.0 to 0.2 cm 2 as well as the median volume of pleural effusion from 50 ml to 0 ml on day 13-15 compared to baseline (Table 3) . Pneumonic lesions appeared sonographically smaller compared to X-ray. In patients with only one lesion, the measured cranio-caudal and ventrodorsal extensions differed by 1.1 cm and 1.4 cm on average. Bigger lesions showed a greater difference.
Concordance between LUS and X-ray during follow-up
In 112 CAP patients correctly diagnosed by LUS and X-ray at baseline, both examinations were 
Discussion
This is the first prospective multicentre study dealing with lung ultrasound in the diagnosis and follow-up of CAP. These results show an excellent sensitivity of 94% and specificity of 98%, comparable with chest X-ray in two planes. LR above 10 and below 0.01 are considered to rule in or rule out diagnosis in most circumstances [12] . Combining typical auscultation and positive LUS finding was about 43 times more likely in patients with CAP and provides strong evidence to rule in the disease. Double negative findings were 0.04 times less likely in patients with CAP, which may be used to rule out CAP. These figures refer to patients with clear LUS findings.
Patients with equivocal results need undergo further diagnostic procedures. This applied to 1.7% of patients after LUS and 6.9% after X-ray. However, comparing X-ray and LUS in diagnosing CAP, it should be mentioned that chest X-ray missed / was inconclusive in about 7% of the cases that were detected by LUS.
In about 8% of patients, CAP may not be detected by LUS, because ultrasound may only detect lesions reaching the pleura. This is in good accordance with two current studies [3, 13] . In the first study, six of 82 patients (7%) did not reveal subpleural alterations. In the second study, patients with primarily X-ray confirmed CAP underwent LUS; 28 of 342 patients (8%) had negative LUS and positive X-ray findings [14] . Parlamento et al. [14] found only one patient of 32 (3%) with negative ultrasound and positive X-ray. Nevertheless, in this study, only 66% of the patients underwent X-ray in two planes. Another study in children [15] who underwent Xray in one plane also showed a high rate of positive LUS. In the present study, CAP was confirmed in about two thirds of patients, as in the study by Parlamento et al. [14] .
CAP was characterised by echopoor lesions with breath-dependant motion, evidence of air bronchogram in about 87%, blurred margins in 75% and basal effusion in half of the patients. In other studies, air bronchogram was detectable in about 70%-97% [3, 13, 16] Necrotic areas within pneumonic lesions were found in only two patients. These echopoor zones within pneumonic infiltrates reflect microabscesses. One patient with microabscess developed empyema. In the other patient, pneumonia showed a complete recovery under antibiotic therapy.
Comparing size of pneumonic lesions in X-ray and LUS, infiltrates were smaller in LUS because sonography may only detect areas directly contacting the pleura. If the lesion becomes broader in central pulmonary regions, it escapes sonographic detection. This finding is in agreement with a study in clinically and radiologically confirmed pneumonia, where the extension of sonographic lesions seemed to be smaller than seen on X-ray in 53 cases (41%) [16] .
Limitations
First, with X-ray in two planes, an imperfect reference test was applied to 83% of patients, probably resulting in an overestimated accuracy of LUS. It is possible that small pneumonic infiltrates may escape detection, because only 17% of patients underwent CT as the approved gold standard. CT was restricted for ethical as well as financial reasons and with respect to radiation exposure to cases with positive LUS and negative/equivocal X-ray. Nevertheless, even in patients with negative LUS and positive X-ray finding, a CT scan would have been preferable. Second, the study was restricted to untreated patients with suspicion of CAP. Patients suffering from hospital-acquired pneumonia and immunodeficiency were excluded because it is assumed that sonomorphology in these cases may differ. Therefore, these conclusions exclusively refer to CAP.
Third, most of the patients were inpatients suffering from CAP. However, it is assumed that the results are comparable to outpatients.
Fourth, the investigations were performed in a multicentre setting. Participating investigators had done at least 100 chest ultrasounds. Therefore, the results reflect the daily routine practice in experienced hands. Nevertheless, LUS represents a technique with a steep learning curve.
Fifth, in five centres contributing 23 or more patients per centre, the prevalence of CAP varied substantially between 39% and 100%. Therefore, predictive values were not reported for the study. They could be calculated for any prevalence from LR. Furthermore, in centres with small numbers of patients, LUS performed perfectly which in principle would be expected for methods with high accuracy. However, selection bias could not be ruled out. 
Conclusions
• This is the first multicentre feasibility study to demonstrate that CAP may be diagnosed and followed up by LUS.
• The results show an excellent sensitivity and specificity at least comparable with chest X-ray in two planes.
• In cases with sonographic evidence of pneumonia, the diagnosis can be established.
• An X-ray or CT of the chest is necessary in cases with negative ultrasound (in about 8% of the patients), if other differential diagnoses are taken into account, or if complications occur.
• LUS offers several different applications, especially if chest X-ray is not available (in point-of-care ultrasonography, in emergency conditions, on airplanes, in rural regions, in resource limited settings, in developing countries, in pregnant women, and even in a general practitioner practice) and in immobilised patients in whom only an X-ray in one plane may be taken.
• Sonographic diagnosis of pneumonia and LUS follow-up allows for rapid therapeutic decisions. 3A, B) . X-ray shows infiltration in the right lower lobe on day 0 (3D), and post-pneumonic residua on day 15 (3E), whereas lung ultrasound shows no lesion on day 15 (3C). yr: years; CAP: community-acquired pneumonia; COPD: chronic obstructive pulmonary disease 
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